Embrace Systems Corp. EMBC 深 滬
等待開盤 08-16 09:30:00 美东时间
13.69
-0.180
-1.30%
華盛通- 最 高14.00
- 今 開13.93
- 成交量 64.66万股
- 最 低 13.6202
- 昨 收 13.87
- 總市值 8.00亿
- 52周最高 21.03
- 市盈率 靜 10.20
- 換手率 1.11%
- 52周最低 9.20
- 委 比 83.75%
- 總股本 5844.25万
- 歷史最高 34.99
- 量 比 0.52
- 振 幅 2.74%
- 歷史最低 9.175
- 每 手 1
- 風險率 3.13%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Embecta shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY25 adjusted EPS guidance.
Embecta shares are trading higher after the company reported better-than-expect...
08-08 20:37
Embecta Raises FY2025 Adj EPS Guidance from $2.70-$2.90 to $2.90-$2.95 vs $2.82 Est; Narrows FY2025 Sales Guidance from $1.073B-$1.090B to $1.078B-$1.085B vs $1.083B Est
Fiscal Year 2025 Updated Financial Guidance:For fiscal year 2025, the Company now expects:Dollars in millions, except percentages and per share dataCurrentPrevious(1)Reported Revenues$1,078 - $1,085$1,073 -
08-08 18:32
Embecta declares $0.15 dividend
Embecta (NASDAQ:EMBC) declares $0.15/share quarterly dividend, in line with previous. Forward yield 5.79% Payable Sept. 15; for shareholders of record Aug. 29; ex-div Aug. 29. See EMBC Dividend Scorec...
08-08 18:28
Earnings Scheduled For August 8, 2025
Companies Reporting Before The Bell • BeOne Medicines (NASDAQ:ONC) is expected ...
08-08 16:32
embecta Announces Quarterly Cash Dividend
Embecta Corp announced a $0.15 per share quarterly dividend, payable on September 15, 2025, to shareholders of record as of August 29, 2025. The company, a global leader in insulin delivery, is expanding into broader medical supplies to enhance lives through innovation and partnerships.
08-08 10:00
An Overview of Embecta's Earnings
Embecta (NASDAQ:EMBC) is gearing up to announce its quarterly earnings on Frida...
08-07 23:03
embecta to Report Fiscal Third Quarter 2025 Financial Results
Embecta Corp. will host a conference call on August 8, 2025, to discuss its fiscal third quarter 2025 financial results, provide an operational update, and answer questions. The call will begin at 8:00 a.m. ET. Participants can access the live webcast via provided links or the company’s investor relations website. A replay will be available later the same day and archived for one year. Embecta, a global medical supplies company advancing its lega...
07-24 21:00
Mizuho Maintains Neutral on Embecta, Lowers Price Target to $12
Mizuho analyst Anthony Petrone maintains Embecta (NASDAQ:EMBC) with a Neutral and lowers the price target from $13 to $12.
07-16 20:25
embecta to Participate in Investor Events
Embecta Corp. announced that its management will participate in several investor events in 2025, including the Goldman Sachs Leveraged Finance and Credit Conference, Jefferies Global Healthcare Conference, Goldman Sachs Global Healthcare Conference, and Truist Securities MedTech Conference. These events feature one-on-one investor meetings and fireside sessions at various locations, with key details as follows: - **Goldman Sachs Tenth Annual Leve...
05-27 21:00
美股大行评级 | 潜在涨幅112.77%！Craig-Hallum上调PLAYSTUDIOS目标价至3美元，评级升至"买入"
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1132955525493317632.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Craig-Hallum：上调PLAYSTUDIOS(MYPS)评级至"买入"，目标价从2美元升至3美元</p> <p>• Leerink Partners：上调Fulcrum Therapeutics(FULC)评级至"
05-24 08:40
